
2.97 Delayed Data As of Mar 22 | ![]() Today’s Change | 1.40 Today|||52-Week Range 8.03 | +17.86% Year-to-Date |
Previous close | 3.05 |
Today’s open | 2.99 |
Day’s range | 2.78 - 3.01 |
Volume | 2,436 |
Average volume (3 months) | 261,045 |
Market cap | $135.4M |
Earnings growth (last year) | +16.66% |
Earnings growth (this year) | -0.75% |
Earnings growth (next 5 years) | -- |
Revenue growth (last year) | -- |
P/E ratio | NM |
Price/Sales | -- |
Price/Book | 0.81 |
---- | ||
YMABY-mAbs Therapeutics ... | -0.17 | -5.69% |
AKBAAkebia Therapeutics ... | -0.04 | -5.86% |
PRPHProphase Labs Inc | +0.14 | +1.80% |
Next reporting date | May 11, 2023 |
EPS forecast (this quarter) | -$0.21 |
Annual revenue (last year) | $0.00 |
Annual profit (last year) | -$35.1M |
Net profit margin | -- |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters --, -- |